You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neovascular age-related macular edema

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

Suspended
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Intravitreal injection of IBI302(dose 1)
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 17, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Austin, Texas
    Retina Consultants of Austin
Jan 16, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Faricimab PFS Configuration
  • Mesa, Arizona
  • +2 more
Jan 2, 2023

Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

Recruiting
  • Neovascular Age-related Macular Degeneration (NVAMD)
  • Diabetic Macular Edema (DME)
  • Phoenix, Arizona
  • +4 more
Jun 14, 2023

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Los Angeles, California
  • +11 more
Jan 11, 2023

Learn More About How Well Aflibercept 8 mg Works in Treating

Not yet recruiting
  • Visual Impairment
  • +2 more
  • Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Australia
  • +5 more
Oct 4, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • +2 more
  • BD311
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Aug 22, 2022

Diabetic Macular Edema, Neovascular Age-related Macular Degeneration Trial in United States (UBX1325)

Completed
  • Diabetic Macular Edema
  • Neovascular Age-related Macular Degeneration
  • Beverly Hills, California
  • +7 more
Mar 8, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • AR-13503 Implant 10.6 Dose
  • +3 more
  • Gilbert, Arizona
  • +5 more
Jun 9, 2022

Gain Clinical Insights Into Roche Ophthalmology Products

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • (no location specified)
Jul 25, 2022

Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration, Diabetic Retinopathy Trial in Durham (AngioVue

Terminated
Has Results
  • Neovascular Age-related Macular Degeneration
  • +4 more
  • AngioVue SD-OCT
  • Durham, North Carolina
    Duke Eye Center
Mar 29, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Brisbane (D-4517.2)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Brisbane, Queensland, Australia
    Nucleus Network (Brisbane)
Sep 19, 2022

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,

Active, not recruiting
  • Age-Related Macular Degeneration
  • +4 more
  • bevacizumab
  • Springfield, Illinois
  • +2 more
Dec 6, 2021

Macular Edema, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration Trial in Puerto Rico, United States (MHU650)

Recruiting
  • Macular Edema
  • +3 more
  • Huntington Beach, California
  • +9 more
Jan 14, 2022

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

Completed
  • Age-related Macular Degeneration
  • +4 more
  • bevacizumab
  • Tucson, Arizona
  • +19 more
Nov 16, 2021

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023